Brind.

Zacks provided stock analysis and estimates for MannKind Corporation on August 6, 2025.

1 report, 1 independent Updated Aug 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

MannKind Corporation

Keep exploring

The entities involved

MannKind Corporation
biopharmaceutical company
- MannKind Corporation stock trades on the Nasdaq electronic exchange, with market data reported by MarketBeat.Thu 18:09

Related events

MannKind Corporation (or its related entity, MeiraGTx Holdings PLC) listed on the electronic stock exchange on September 1, 2026.Sep 7

Coverage

Newest first; wire copies grouped

Aug 6ZacksMannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates For the quarter ended June 2025, MannKind (MNKD) reported revenue of $76.53 million, up 5.7% over the same period last ye